Funding for Community Health

Since 2001, Komen Lowcountry has awarded more than $7 million in grants for local breast health programs!  This investment has funded breast cancer detection, treatment support services and breast health education in 17 South Carolina counties. The funds Komen Lowcountry grants to non-profits serving our local citizens have made a positive difference in the lives of those facing breast cancer, as well as their families and their communities.

The goal of our Community Grants program is to provide funding for high impact breast cancer programs that work to reduce rates of late stage diagnosis and breast cancer mortality with an emphasis on eliminating breast cancer disparities. 

Grants 2013-BJHCHS

2016-17  Community Grant Recipients

Through our 2016-17 Community Grants, Komen Lowcountry has invested more than $170,000 in screening, diagnosis, treatment support and education programs.

  • Allendale County Hospital
  • Beaufort, Jasper, Hampton Comprehensive Health Services, Inc.
  • McLeod Regional Medical Center

 Our Research Investment

Komen Lowcountry has also invested more than $3 million in global research through Susan G. Komen’s Research Awards programs. Two South Carolina research projects are currently funded by the program

Adam Soloff, Ph.D.
Adam Soloff, Ph.D.
Medical University of South Carolina

Dr. Soloff has been awarded $450,000 for pre-clinical testing of a novel vaccine that induces highly specialized cells within the immune system to seek out cancer cells in combination with a new investigational drug, anti-PD-L1, which blocks the ability of cancer cells to hide from the immune system. If successful, this treatment strategy could not only kill existing breast cancer cells, but also produce long-term immune memory that will prevent breast cancer recurrence.

Martina McDermott, Ph.D.
Martina McDermott, Ph. D.
University of South Carolina

Dr. McDermott has been awarded $180,000 to determine whether the addition of a newly developed drug that targets a protein called CDK8 to ER and HER2-targeted therapies will increase the response to treatment and prevent  the development of drug resistance. Dr. McDermott is inspired by her mother’s battle against breast cancer.

For more detailed information about Research Grants, click here.